Skip to content

FP7

MM4TB

More Medicines for Tuberculosis

Programme
Seventh Framework Programme
Started
Ends
Duration
66 months
Total cost
EUR 16,698,641
EU contribution
EUR 11,873,052
Participants
27 from 13 countries
Topic
FP7_HEALTH.2010.2.3.2-1
Grant agreement
260872

Coordinated by Ecole Polytechnique Federale de Lausanne (CHSwitzerland).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium
OrganisationCountryRoleEU contributionRecognised by
Ecole Polytechnique Federale de LausanneCHSwitzerlandCoordinatorEUR 2,062,998PIC (1.00)
Eidgenoessische Technische Hochschule ZuerichCHSwitzerlandParticipantEUR 450,000PIC (1.00)
Fondation Innovative Medicines for Tuberculosis (IM4TB)CHSwitzerlandParticipantEUR 455,148PIC (1.00)
Sciprom SarlCHSwitzerlandParticipantEUR 150,516PIC (1.00)
Alere Technologies GmbHDEGermanyParticipantEUR 150,000PIC (1.00)
Sanofi-Aventis Deutschland GmbHDEGermanyParticipantEUR 215,002PIC (1.00)
Universidad de ZaragozaESSpainParticipantEUR 260,000known name (0.95)
Universidad del Pais Vasco/ Euskal Herriko UnibertsitateaESSpainParticipantEUR 260,000known name (0.95)
Institut National de la Sante et de la Recherche MedicaleFRFranceParticipantEUR 447,803known name (0.95)
Institut PasteurFRFranceParticipantEUR 492,920PIC (1.00)
Sanofi-Aventis Recherche & DeveloppementFRFranceParticipantEUR 384,998PIC (1.00)
John Innes CentreGBUnited KingdomParticipantEUR 400,000known name (0.95)
Queen Mary University of LondonGBUnited KingdomParticipantEUR 217,651PIC (1.00)
The Chancellor Masters and Scholars of the University of CambridgeGBUnited KingdomParticipantEUR 542,462known name (0.95)
Vichem Chemie Kutato Korlatolt Felelossegu TarsasagHUHungaryParticipantEUR 439,997PIC (1.00)
AstraZeneca India Pvt Ltd.INIndiaParticipantEUR 416,372PIC (1.00)
Cellworks Research India Private LimitedINIndiaParticipantEUR 250,000PIC (1.00)
Indian Institute of ScienceINIndiaParticipantEUR 162,000PIC (1.00)
TYDOCK PHARMA S.r.lITItalyParticipantEUR 499,800PIC (1.00)
Universita Degli Studi del Piemonte Orientale Amedeo AvogadroITItalyParticipantEUR 386,800known name (0.95)
Universita Degli Studi di PadovaITItalyParticipantEUR 374,992known name (0.95)
Universita Degli Studi di PaviaITItalyParticipantEUR 648,000known name (0.95)
A.N. Bakh Institute of Biochemistry of the Russian Academy of SciencesRURussiaParticipantEUR 532,000PIC (1.00)
Uppsala UniversitetSESwedenParticipantEUR 730,000known name (0.95)
Univerzita Komenskeho v BratislaveSKSlovakiaParticipantEUR 424,843known name (0.95)
Collaborative Drug Discovery Inc CorporationUSUnited StatesParticipantEUR 270,000PIC (1.00)
University of Cape TownZASouth AfricaParticipantEUR 248,750PIC (1.00)

Changes of the consortium

First seen on with 27 participants from 13 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.